Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James L. Lordan is active.

Publication


Featured researches published by James L. Lordan.


The Journal of Allergy and Clinical Immunology | 2000

Epithelial-mesenchymal interactions in the pathogenesis of asthma.

Stephen T. Holgate; Donna E. Davies; Peter M. Lackie; Susan J. Wilson; Sarah M. Puddicombe; James L. Lordan

Abstract During lung development, repair, and inflammation, local production of cytokines (eg, transforming growth factor-β) and growth factors (eg, epidermal growth factor) by epithelial and mesenchymal cells mediate bidirectional growth control effectively creating an epithelial-mesenchymal trophic unit. In asthma the bronchial epithelium is highly abnormal, with structural changes involving separation of columnar cells from their basal attachments and functional changes including increased expression and release of proinflammatory cytokines, growth factors, and mediator-generating enzymes. Beneath this damaged structure there is an increase in the number of subepithelial myofibroblasts that deposit interstitial collagens causing thickening and increased density of the subepithelial basement membrane. Our recent studies suggest that the extent of epithelial damage in asthma may be the result of impaired epidermal growth factor receptor–mediated repair. In view of the close spatial relationship between the damaged epithelium and the underlying myofibroblasts, we propose that impaired epithelial repair cooperates with the TH2 environment to shift the set point for communication within the trophic unit. This leads to myofibroblast activation, excessive matrix deposition, and production of mediators that propagate and amplify the remodeling responses throughout the airway wall. (J Allergy Clin Immunol 2000;105:193-204.)


Journal of Immunology | 2002

Cooperative Effects of Th2 Cytokines and Allergen on Normal and Asthmatic Bronchial Epithelial Cells

James L. Lordan; F. Bucchieri; Audrey Richter; Athanassias Konstantinidis; John W. Holloway; Matthew Thornber; Sarah M. Puddicombe; Diana Buchanan; Susan J. Wilson; Ratko Djukanovic; Stephen T. Holgate; Donna E. Davies

In sensitized individuals, exposure to allergens such as Dermatophagoides pteronyssinus (Der p) causes Th2 polarization and release of cytokines, including IL-4 and IL-13. Because Der p extracts also have direct effects on epithelial cells, we hypothesized that allergen augments the effects of Th2 cytokines by promoting mediator release from the bronchial epithelium in allergic asthma. To test our hypothesis, primary bronchial epithelial cultures were grown from bronchial brushings of normal and atopic asthmatic subjects. RT-PCR showed that each culture expressed IL-4Rα, common γ-chain, and IL-13Rα1, as well as IL-13Rα2, which negatively regulates IL-13 signaling; FACS analysis confirmed IL-13Rα2 protein expression. Exposure of epithelial cultures to either Der p extracts, TNF-α, IL-4, or IL-13 enhanced GM-CSF and IL-8 release, and this was partially suppressible by corticosteroids. Simultaneous exposure of the epithelial cultures to IL-4 or IL-13 together with Der p resulted in a further increase in cytokine release, which was at least additive. Release of TGF-α was also increased by TNF-α and combinations of IL-4, IL-13, and Der p; however, this stimulation was only significant in the asthma-derived cultures. These data suggest that, in an allergic environment, Th2 cytokines and allergen have the potential to sustain airway inflammation through a cooperative effect on cytokine release by the bronchial epithelium. Our novel finding that IL-4, IL-13, and allergen enhance release of TGF-α, a ligand for the epidermal growth factor receptor that stimulates fibroblast proliferation and goblet cell differentiation, provides a potential link between allergen exposure, Th2 cytokines, and airway remodelling in asthma.


Archive | 1999

Anti-Inflammatory Drugs in Asthma: The Pathophysiology of Asthma

James L. Lordan; Ratko Djukanovic

Asthma is a chronic condition characterised by widespread, variable and reversible airflow obstruction which is either spontaneous or pharmacologically induced. The underlying pathophysiological feature of asthma is increased airway responsiveness which develops on a basis of diffuse bronchial inflammation. The prevalence of asthma is increasing worldwide despite improved treatment which has resulted from a more comprehensive understanding of its pathogenesis [1]. In most countries asthma affects between 4 and 8% of the population, with a trend towards an increase in morbidity as judged by increased hospital admissions [2]. The reasons for this are unclear, but environmental factors such as indoor and outdoor air pollution and changes in lifestyle are considered to be amongst the contributing factors.


Cytokine | 2002

ANALYSIS OF NOVEL DISEASE-RELATED GENES IN BRONCHIAL ASTHMA

Noriko Yuyama; Donna E. Davies; Mina Akaiwa; Keiko Matsui; Yuhei Hamasaki; Yoshinori Suminami; Ning Lu Yoshida; Miyako Maeda; Anita Pandit; James L. Lordan; Yumiko Kamogawa; Kazuhiko Arima; Fumio Nagumo; Mitsuhiko Sugimachi; Ann E. Berger; Ivan M. Richards; Steven L. Roberds; Tetsuji Yamashita; Fumio Kishi; Hiroshi Kato; Ken-ichi Arai; Koichi Ohshima; Jutaro Tadano; Naotaka Hamasaki; Shoichiro Miyatake; Yuji Sugita; Stephen T. Holgate; Kenji Izuhara


The Journal of Allergy and Clinical Immunology | 2001

Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium

Rebecca Mullings; Susan J. Wilson; Sarah M. Puddicombe; James L. Lordan; F. Bucchieri; Ratko Djukanovic; Peter H. Howarth; Steven Harper; Stephen T. Holgate; Donna E. Davies


The Journal of Allergy and Clinical Immunology | 2001

The role of CD28-B7 costimulation in allergen-induced cytokine release by bronchial mucosa from patients with moderately severe asthma

James L. Lordan; Donna E. Davies; Susan J. Wilson; Gordon Dent; Andrea Corkhill; Zeina Jaffar; Kevan Roberts; Ratko Djukanovic; Stephen T. Holgate


Journal of The Royal College of Physicians of London | 1999

Recent developments in the pathogenesis and epidemiological trends of asthma.

James L. Lordan; Stephen T. Holgate


Revue Francaise D Allergologie Et D Immunologie Clinique | 2000

Pathophysiology and clinical aspects of respiratory allergies with reference to asthma

James L. Lordan; Ratko Djukanovic; Stephen T. Holgate


Allergology International | 2003

Epithelial-mesenchymal interactions in the pathogenesis of asthma

Stephen T. Holgate; Donna E. Davies; Sarah M. Puddicombe; Audrey Richter; Peter M. Lackie; James L. Lordan; Peter H. Howarth


Archive | 2002

Role of IgE in Asthma Pathogenesis and Novel Therapeutic Strategies

James L. Lordan; Stephen Holgate; Ian Sayers

Collaboration


Dive into the James L. Lordan's collaboration.

Top Co-Authors

Avatar

Donna E. Davies

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarah M. Puddicombe

Southampton General Hospital

View shared research outputs
Top Co-Authors

Avatar

Susan J. Wilson

University of Southampton

View shared research outputs
Top Co-Authors

Avatar

Peter M. Lackie

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Bucchieri

Southampton General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Audrey Richter

Southampton General Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge